» Articles » PMID: 11291929

Early Severe Acute Pancreatitis: Characteristics of a New Subgroup

Overview
Journal Pancreas
Specialty Gastroenterology
Date 2001 Apr 9
PMID 11291929
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

This study focuses on patients with severe acute pancreatitis complicated by organ failure within the initial phase of the disease. Data of 158 patients with severe acute pancreatitis (SAP) admitted to hospital within 72 hours after onset of symptoms were prospectively documented and analyzed for the occurrence of early severe acute pancreatitis (ESAP). ESAP was defined as presence of organ failure (OF) at admission. Forty-seven (30%) patients had ESAP, compared with 111 patients without OF (SAP group). In a multivariate analysis, the main factor predisposing to ESAP was the presence of extended pancreatic necrosis (odds ratio, 3.8), whereas biliary pancreatitis was associated with a slightly lower risk compared with alcoholic pancreatitis (odds ratio, 0.34). Compared with SAP, patients with ESAP more frequently developed intractable organ failure, which posed the indication for surgical treatment. Surgical necrosectomy due to progressive OF had to be performed in 89% of the ESAP patients and in 60% of the SAP patients. The incidence of infected pancreatic necrosis did not differ between both groups (23 vs. 21%). Mortality was significantly higher in ESAP (42 vs. 14%; p = 0.0003). ESAP is characterized by the presence of extended pancreatic necrosis and a complicated clinical course. Intractable organ failure is a frequent finding. Given the poor prognosis of ESAP, these patients should be treated in specialized intensive care units.

Citing Articles

Early cholecystectomy cannot be regarded as a mortality risk factor in moderate and severe acute biliary pancreatitis.

Al Taweel B, Tzedakis S, Panaro F Hepatobiliary Surg Nutr. 2024; 13(1):109-111.

PMID: 38322210 PMC: 10839710. DOI: 10.21037/hbsn-23-593.


Ketogenic Diet Exacerbates L-Arginine-Induced Acute Pancreatitis and Reveals the Therapeutic Potential of Butyrate.

Xia H, Guo J, Shen J, Jiang S, Han S, Li L Nutrients. 2023; 15(20).

PMID: 37892502 PMC: 10609823. DOI: 10.3390/nu15204427.


Activation of AMPK ameliorates acute severe pancreatitis by suppressing pancreatic acinar cell necroptosis in obese mice models.

Wang K, Zhao A, Tayier D, Tan K, Song W, Cheng Q Cell Death Discov. 2023; 9(1):363.

PMID: 37777514 PMC: 10542799. DOI: 10.1038/s41420-023-01655-z.


Therapeutic outcomes of early and delayed endoscopic retrograde cholangiopancreatography and percutaneous transhepatic cholangial drainage in patients with obstructive severe acute biliary pancreatitis.

Zhang X, Sun J, Wu Y, Xie M, Li C, Lv D J Clin Transl Res. 2023; 9(3):160-167.

PMID: 37457545 PMC: 10339408.


Clinical Evaluation of Continuous Renal Replacement Therapy Combined with Peritoneal Lavage for Severe Acute Pancreatitis: A Retrospective Cohort Study.

Jiang W, Zhao H, Chen L, Tang X, Deng Z Med Sci Monit. 2023; 29:e939314.

PMID: 37041732 PMC: 10108656. DOI: 10.12659/MSM.939314.